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Variables
With Prior MI
N¼8357
Without Prior MI
N¼23176 p Value
Death 279 (3.9) 551 (2.7) <0.0001
Cardiac death 172 (2.4) 333 (1.5) 0.0001
Myocardial reinfarction 535 (6.8) 1031 (4.6) <0.0001
Target vessel revascularization 599 (7.6) 1623 (7.4) 0.53
Deﬁnite/probable stent
thrombosis
121 (1.7) 246 (1.1) 0.006
Major adverse cardiac events 1188 (15.1) 2761 (12.5) <0.0001
Data presented as N (%)
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Background: Chronic kidney disease (CKD) is a health problem, associated with
high cardiovascular events. Increased cardiovascular risk cannot be explained only by
traditional risk factors. Patients with renal dysfunction have signiﬁcant disturbances in
lipoprotein metabolism. Especially, high-density lipoprotein cholesterol (HDL-C) and
triglyceride (TG) in these patients becomes dysfunctional. However, it remained un-
certain whether the TG to HDL-C ratio is associated with adverse cardiovascular (CV)
events in patients with CKD after coronary intervention.
Methods: Between 1999 and 2011, a total of 3508 patients received PCI. Among
them, consecutive 3306 patients whose data are available regarding laboratory and
procedural data at PCI without hemodialysis were analyzed. All eligible patients were
divided into 2 groups according to medium TG/HDL-C level (High TG/HDL-C>¼
2.80 group and Low TG/HDL-C< 2.80 group). We examined the association of TG/
HDL-C with CV events (all-cause mortality, acute coronary syndrome (ACS) and
target vessel revascularization) according to renal function. Estimated GFR (eGFR)
was calculated using the eGFRcreat. Patients with eGFR< 60 ml/min per 1.73 m2 for
3 months are deﬁned as CKD. The effect of increasing TG/HDL-C serum levels was
assessed using Cox proportional hazard models.
Results: The median follow-up period was 4.7 years. Cumulative event-free survival
was signiﬁcantly lower in the high TG/HDL-C group than in the low TG/HDL-C
group (P¼0.0006) in patients with CKD. In multivariable analysis, higher TG/HDL-C
was associated with increased the risk of CV events and mortality plus ACS (hazard
ratio [HR], 1.25, 95% conﬁdence interval [95% CI], 1.03-1.54 [P¼0.025]; HR, 1.31,
95% CI, 1.03-1.69 [P¼0.031]). Conversely, in patients without CKD, higher TG/
HDL-C did not associate with higher risk for CV events and mortality plus ACS (HR,
0.94, 95% CI, 0.82-1.09 [P¼0.43]; HR, 1.01, 95% CI, 0.84-1.21 [P¼0.93]). There
were no signiﬁcant differences in clinical and angiographic background between the
high TG/HDL group and low TG/HDL group.
Conclusions: High TG/HDL-C level could be associated with poor prognosis
following PCI in patients with CKD.
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Background: The Framingham Risk Score (FRS) has been shown to be effective in
predicting the risk of cardiovascular disease and primary events such as myocardial
infarction. However, there is little evidence showing its effective use in predicting
secondary events in patients with established coronary artery disease. This study
aims to evaluate the utility of the FRS in predicting secondary events in patients
following PCI at a tertiary referral center across a 17-year period of time and to
ascertain whether there is a change in its utility in predicting secondary events
across this time period.
Methods: The FRS of 25,519 consecutive patients presenting to the catheterization
laboratory at a tertiary referral center between January 1994 and December 2010
was determined (71% male, mean age 66.5+/-12.1, mean score 7.0+/-3.3). Patients
were divided into 4 groups depending on their 10-year cardiovascular disease risk
(< 5%, 5-10%, 10-20% and >20%) and were followed up for a median duration
of 109 months (IQR 63-155) for secondary events including myocardial infarction,
death and target-vessel revascularization. The association between FRS and sec-
ondary event rate was then assessed. Patients were also separately divided into 5
equal temporal groups depending on the date of PCI and the association between
each group’s FRS and secondary event rate was assessed and compared between
groups.
Results: The FRS was shown to be signiﬁcantly associated with secondary event
rate following PCI (p< 0.001) but the differences between risk groups were notB36 JACC Vol 64/11/Suppl B j Septemblarge (C-statistic 0.54). To assess for temporal changes in the association between
FRS and secondary event rate, the data from the 5 temporal groups was ﬁt to a
Cox model with an interaction between FRS and time . The association between
FRS and secondary event rate across the different temporal groups did not change
signiﬁcantly (p¼0.10).
Conclusions: This study shows that the FRS may be used to predict secondary
events in patients following PCI but lacks the ability to discriminate very well
between high and low risk patients. The FRS has also been shown to retain its
utility in predicting secondary events amongst these patients across different pe-
riods of time.
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Background: Pts with prior myocardial infarction (MI) undergoing percutaneous
coronary intervention (PCI) are thought to have worse long-term outcomes, but the
magnitude of this impact remains unknown. We sought to assess the impact of prior
MI on 1-year outcomes in patients undergoing PCI.
Methods: Patient-level data from 18 prospective randomized trials (RAVEL, E-
SIRIUS, SIRIUS, C-SIRIUS, TAXUS I-II, TAXUS IV-VI, ENDEAVOR II-IV,
SPIRIT II-IV, ACUITY, HORIZONS-AMI and COMPARE) were pooled. Pts were
stratiﬁed by history of prior MI. Adverse ischemic outcomes were compared between
the 2 groups at 1 year.
Results: Among 31,533 patients, prior MI was present in 8,357 (26.5%) pts. Pts with
prior MI were more likely to be male, current smokers and have diabetes, hypertension
and hyperlipidemia. Pts with vs. without prior MI had signiﬁcantly higher 1-year rates
of death (3.9% vs. 2.7%, p< 0.0001), cardiac death (2.4% vs. 1.5%, p¼0.0001),
subsequent reinfarction (6.8% vs. 4.6%, P< 0.0001), deﬁnite/probable stent throm-
bosis (1.7% vs. 1.1%, p¼0.006), major adverse cardiac events (15.1% vs. 12.5, p<
0.000). By multivariable analysis, prior MI was an independent predictor of death (HR
[95%CI] ¼1.50 [1.18, 1.90], p¼0.0008) and recurrent MI (HR [95%CI]¼1.38 [1.16,
1.63], p¼0.0002) at 1 year.
Conclusions: Pts with a history of prior MI have signiﬁcantly worse long-term out-
comes despite signiﬁcant advances in PCI.
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